Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease

Reference : Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease


	Document type :	Scientific journals : Article
	Discipline(s) :	Life sciences : Multidisciplinary, general & others
	To cite this reference:	http://hdl.handle.net/10993/30750

Title :	Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
Language :	English
Author, co-author :	Spathis, Athanasios []
	Asvos, Xenophon []
	Ziavra, Despina []
	Karampelas, Theodoros []
	Topouzis, Stavros []
	Cournia, Zoe []
	Qing, Xiaobing [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
	Alexakos, Pavlos []
	Smits, Lisa [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
	Dalla, Christina []
	Rideout, Hardy []
	Schwamborn, Jens Christian [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit >]
	Tamvakopoulos, Constantin []
	Fokas, Demosthenes []
	Vassilatis, Demetrios []
Publication date :	2017
Journal title :	Proceedings of the National Academy of Sciences of the United States of America
Publisher :	National Academy of Sciences
Peer reviewed :	Yes (verified by ORBi^lu)
Audience :	International
ISSN :	0027-8424
e-ISSN :	1091-6490
City :	Washington
Country :	DC
Permalink :	http://hdl.handle.net/10993/30750

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Limited access	2017_Spathis.pdf		Publisher postprint	1.74 MB	Request a copy

All documents in ORBi^lu are protected by a user license.